Whitehawk Therapeutics, Inc. (WHWK)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $3.46
- As of
Kresmion compiles this page from WHWK's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Whitehawk Therapeutics, Inc. (WHWK): 5 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-10.
See the full WHWK dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for WHWK on one page. Preview it with sample data, then open it live with a free account.
Preview the WHWK dossierActive events for WHWK
- high13F: large increase
Point72 Asset Management, L.P. added +104% to WHWK (2026Q2)
- mediumEarnings above estimates
Q2-2026: Beat consensus by 33.7%, EPS $-0.20 vs $-0.3018 estimate
- mediumEarnings below estimates
Q3-2025: Missed consensus by 482.4% - EPS $-0.26 vs $0.068 estimate
- mediumEarnings below estimates
Q2-2025: Missed consensus by 251.0% - EPS $-0.76 vs $0.5032 estimate
- mediumEarnings below estimates
Missed consensus by 482.4% - EPS $-0.26 vs $0.068 estimate
FREE, NO ACCOUNT
Every event on WHWK, as it fires
You are seeing 5 of 7 events recorded on WHWK since 2026-06-01.
The five above landed across 4 days. The other 2 were recorded on those same days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in WHWK (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLCCUSIP 00032Q104 · 2026Q2 | $1.9M | 0.00% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 00032Q104 · 2026Q2 | $1.7M | 0.00% | , |
| TWO SIGMA INVESTMENTS, LPCUSIP 00032Q104 · 2026Q2 | $1.4M | 0.00% | , |
| Point72 Asset Management, L.P.CUSIP 00032Q104 · 2026Q2 | $262K | 0.00% | , |
| CITADEL ADVISORS LLCCUSIP 00032Q104 · 2026Q2 | $138K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, WHWK
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
WHWK against its peers
WHWK's operating margin of -1601.1% ranks in the 18th percentile of 19 Biotechnology sub-industry peers, fiscal period ending 2025-12-31.
| Metric | WHWK | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 7.1M USD | 13.9M USD | 31 | 17 |
| Gross margin | 89.4% | 64.3% | 81 | 7 |
| Operating margin | -1601.1% | -599.8% | 18 | 19 |
| Net margin | -288.3% | -265.2% | 48 | 19 |
| Return on equity | -15.1% | -49.7% | 80 | 22 |
Peers (24): DTIL, CGEN, PRQR, XGN, ACOG, IVVD, ELDN, RNAC, YARW, KRRO, EVMN, NAGE, SION, PEPG, ORMP, TRDA, PYXS, ALEC, IPHA, PLX, ADAG, ALXO, CAMP, BBOT. Left out: SCNLD (no annual filing). Fiscal period ending 2025-12-31. Every figure is one full fiscal year read from one annual filing (WHWK: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow WHWK on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to WHWK for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.